Analysts and consensus
Stock coverage
The stock, part of the FTSE MIB index since the end of 2018 and part of the Stoxx Europe 600 since June 2019, is covered by 18 analysts, who actively follow Amplifon with specific studies and analysis.
Here is the list of analysts following Amplifon, together with a summary of their recommendations and an overall consensus.
Please note
The list below may not be complete and is subject to change. Please note that all the opinions, estimates or forecasts relating to Amplifon's results made by the analysts are personal opinions and do not represent opinions, forecasts or previews made by Amplifon or Amplifon's management. The fact that Amplifon provides such information does not involve - and for this reason this constitutes an express warning to the contrary - any endorsement of the research, conclusions and recommendations supplied by these analysts.
Recommendations
Analysts
Broker
|
AlphaValue |
|
Banca Akros |
|
Bank of America |
|
Barclays |
|
Bernstein Research |
|
BNP Paribas Exane |
|
Carnegie |
|
Citi |
|
Equita SIM |
|
Goldman Sachs |
|
Intermonte |
|
Intesa Sanpaolo |
|
Jefferies |
|
JP Morgan |
|
Kepler Cheuvreux |
|
Mediobanca |
|
Oddo BHF |
|
RBC Capital Markets |
Analyst
|
AlphaValue |
|
|
Banca Akros |
|
|
Bank of America |
|
|
Barclays |
|
|
Bernstein Research |
|
|
BNP Paribas Exane |
|
|
Carnegie |
|
|
Citi |
|
|
Equita SIM |
|
|
Goldman Sachs |
|
|
Intermonte |
|
|
Intesa Sanpaolo |
|
|
Jefferies |
|
|
JP Morgan |
|
|
Kepler Cheuvreux |
|
|
Mediobanca |
|
|
Oddo BHF |
|
|
RBC Capital Markets |
Target price (€)
|
AlphaValue |
30.2 |
|
Banca Akros |
16.0 |
|
Bank of America |
16.0 |
|
Barclays |
19.5 |
|
Bernstein Research |
15.95 |
|
BNP Paribas Exane |
19.0 |
|
Carnegie |
16.9 |
|
Citi |
17.0 |
|
Equita SIM |
23.0 |
|
Goldman Sachs |
14.5 |
|
Intermonte |
19.0 |
|
Intesa Sanpaolo |
17.0 |
|
Jefferies |
20.0 |
|
JP Morgan |
22.6 |
|
Kepler Cheuvreux |
16.7 |
|
Mediobanca |
19.5 |
|
Oddo BHF |
18.0 |
|
RBC Capital Markets |
15.0 |
Recommendation
|
AlphaValue |
Buy |
|
Banca Akros |
Accumulate |
|
Bank of America |
Neutral |
|
Barclays |
Overweight |
|
Bernstein Research |
Market-perform |
|
BNP Paribas Exane |
Outperform |
|
Carnegie |
Hold |
|
Citi |
Neutral |
|
Equita SIM |
Buy |
|
Goldman Sachs |
Neutral |
|
Intermonte |
Neutral |
|
Intesa Sanpaolo |
Neutral |
|
Jefferies |
Buy |
|
JP Morgan |
Neutral |
|
Kepler Cheuvreux |
Hold |
|
Mediobanca |
Neutral |
|
Oddo BHF |
Neutral |
|
RBC Capital Markets |
Neutral |
Date
|
AlphaValue |
30/10/2025 |
|
Banca Akros |
31/10/2025 |
|
Bank of America |
30/10/2025 |
|
Barclays |
31/10/2025 |
|
Bernstein Research |
03/11/2025 |
|
BNP Paribas Exane |
30/10/2025 |
|
Carnegie |
30/10/2025 |
|
Citi |
30/10/2025 |
|
Equita SIM |
29/10/2025 |
|
Goldman Sachs |
30/10/2025 |
|
Intermonte |
30/10/2025 |
|
Intesa Sanpaolo |
20/08/2025 |
|
Jefferies |
30/10/2025 |
|
JP Morgan |
30/10/2025 |
|
Kepler Cheuvreux |
30/10/2025 |
|
Mediobanca |
30/10/2025 |
|
Oddo BHF |
30/10/2025 |
|
RBC Capital Markets |
18/11/2025 |
Consensus
The consensus provided below is based on the average of 12 analysts' estimates and it was updated on November 24th, 2025.
Consensus
|
Revenues (€m) |
|
EBITDA adjusted (€m) 1 |
|
EPS adjusted2 |
FY 2025E
|
Revenues (€m) |
2,413.8 |
|
EBITDA adjusted (€m) 1 |
549.9 |
|
EPS adjusted2 |
0.72 |
FY 2026E
|
Revenues (€m) |
2,526.3 |
|
EBITDA adjusted (€m) 1 |
590.9 |
|
EPS adjusted2 |
0.84 |
1 Adjusted income statement figure which excludes the effect of unusual, infrequent or unrelated items (expenses or income) to the normal course of business
2 EPS adjusted for the effect of unusual, infrequent or unrelated items (expenses or income) to the normal course of business, including Purchase Price Allocation
